US stock customer concentration analysis and revenue diversification assessment for business risk evaluation and investment safety assessment. We identify companies with too much dependency on single customers or concentrated revenue sources that could pose risks. We provide customer analysis, revenue diversification scoring, and concentration risk assessment for comprehensive coverage. Understand business risks with our comprehensive concentration analysis and diversification tools for safer investing.
As of April 16, 2026, The Oncology Institute Inc. (TOI) is trading at $3.54, posting an intraday gain of 3.21% during regular market hours. This analysis examines key technical price levels for TOI, recent market context for the specialty oncology care sector, and potential short-term price scenarios that market participants may monitor. No recently released quarterly earnings data is available for TOI at the time of writing, so current price action is largely being driven by technical flows and
The (TOI) Stock: Valuation Metrics (+3.21%) 2026-04-16 - Turnaround Stocks
TOI - Stock Analysis
3364 Comments
1200 Likes
1
Luticia
Loyal User
2 hours ago
Who else is trying to keep up with this trend?
👍 78
Reply
2
Edi
Regular Reader
5 hours ago
Real-time US stock currency and international exposure analysis for understanding global business impacts. We help you understand how exchange rates and international operations affect your portfolio companies.
👍 113
Reply
3
Dalton
Elite Member
1 day ago
Let me find my people real quick.
👍 91
Reply
4
Ezzah
Registered User
1 day ago
Get expert US stock recommendations backed by technical analysis, market trends, and institutional activity to maximize returns while minimizing downside risk. Our team of experienced analysts constantly monitors market movements to identify the most promising opportunities for your portfolio.
👍 61
Reply
5
Amil
Active Reader
2 days ago
Who else is curious but unsure?
👍 130
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.